Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
4 Patents
#55 in Petach Tikva
#1,415 in Israel
Macrocure, Ltd.
Forward Citations = 0
8 inventors:
Macrocure, Ltd.
% Expired Patents = 75.0
EPO Patents = 2
Forward Citations = 0
Loading Chart...
Loading Chart...
8 inventors (with patents filed for the assignee):
Marina Bubis (4 out of 9 patents)
Mitchell Shirvan (4 out of 4 patents)
Eilat Bain (4 out of 4 patents)
4. Irene Ginis (3 out of 3 patents)
5. Eilat Shinar (2 out of 2 patents)
6. Orit Frenkel (2 out of 2 patents)
7. Adi Zuloff-Shani (2 out of 2 patents)
8. Irene Gillis (1 out of 1 patent)
4 patents:
Company Overview
Macrocure, Ltd. is a biotechnology company specializing in the development and commercialization of advanced cell therapy products for the treatment of chronic wounds. Their flagship product, CureXcell, is a cell-based therapy that promotes wound healing and tissue regeneration. With a focus on innovative solutions and cutting-edge technology, Macrocure aims to improve the lives of patients suffering from chronic wounds worldwide.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Macrocure, Ltd.. Retrieved from https://idiyas.com/company/macrocure
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]